Review for "Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1111/dom.70538/v2/review1

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Diabetes Management and Research